How should rifampin be used for treating brucellosis, including appropriate dosing and duration?

Rifampin in Brucellosis

For uncomplicated brucellosis in adults, rifampin should be dosed at 600-900 mg once daily in the morning for 6 weeks, combined with doxycycline 100 mg twice daily for 6 weeks. This doxycycline-rifampin (DOX-RIF) combination represents one of two first-line treatment options with an AI recommendation grade 1.

Dosing and Administration

Rifampin dosing:

• Adults: 600-900 mg daily as a single morning dose for 6 weeks 1
• Pediatric patients: 10-20 mg/kg daily (not to exceed 600 mg/day) 2
• Administer 1 hour before or 2 hours after meals with a full glass of water 2

Treatment Regimen Hierarchy

The Ioannina Recommendations (2007) establish a clear treatment hierarchy 1:

First-Line Options (AI Grade):

1. Doxycycline + Streptomycin: DOX 100 mg twice daily for 6 weeks + STR 15 mg/kg daily IM for 2-3 weeks
2. Doxycycline + Rifampin: DOX 100 mg twice daily for 6 weeks + RIF 600-900 mg daily for 6 weeks

Acceptable Alternative (BI Grade):

• Doxycycline + Gentamicin: DOX 100 mg twice daily for 6 weeks + GENT 5 mg/kg daily IV/IM for 7 days 1

Efficacy Considerations

The DOX-RIF regimen has important limitations:

• Relapse rates of 5-15% in uncomplicated cases 1
• One study showed 38.8% relapse rate with 30-day DOX-RIF versus 7.1% with DOX-STR 3
• A 45-day DOX-RIF regimen showed 14.4% failure/relapse rate versus 5.9% with DOX-STR, though this difference was not statistically significant 4
• May be less effective in spondylitis: All 3 patients with spondylitis failed DOX-RIF therapy in one trial 4

Why rifampin is still recommended despite higher relapse rates:

• Convenience: entirely oral regimen
• Avoids aminoglycoside toxicity and injection requirements
• The 6-week duration (versus 30 days in older studies) improves outcomes 1

Special Populations

Pregnant Women:

Rifampin 900 mg once daily for 6 weeks is the drug of choice 5. Tetracyclines are contraindicated. Sulfamethoxazole-trimethoprim + rifampin is most commonly used, though adverse obstetric outcomes occur in 16% of cases 6.

Children <8 years:

Rifampin 15 mg/kg daily + trimethoprim-sulfamethoxazole for 45 days is preferred 5. Alternative: rifampin for 45 days + gentamicin 5-6 mg/kg/day for first 5 days 5.

Neurobrucellosis:

Consider rifampin 600 mg twice daily IV + trimethoprim-sulfamethoxazole for 6-8 weeks 7. CNS penetration is critical.

Critical Pitfalls

Public health concern: In regions where tuberculosis and brucellosis coexist, using rifampin for brucellosis risks promoting mycobacterial resistance to this critical anti-TB drug. The public health impact may exceed the cumulative brucellosis morbidity 1.

Duration matters: Studies using 30-day regimens showed significantly higher relapse rates. The full 6-week course is essential 3.

Focal disease: Patients with spondylitis or endocarditis may require longer treatment duration or alternative regimens, as DOX-RIF appears less effective 4.

Monotherapy is inadequate: Rifampin monotherapy has shown varying and generally poor results 1. Always use combination therapy.

Practical Algorithm

1. Uncomplicated brucellosis in adults: Choose DOX-STR (preferred for lowest relapse) or DOX-RIF (if oral route strongly preferred)
2. Spondylitis present: Strongly favor DOX-STR over DOX-RIF; extend treatment duration
3. Aminoglycoside contraindicated: Use DOX-RIF for full 6 weeks
4. Pregnant women: Rifampin 900 mg daily (avoid tetracyclines)
5. Children <8 years: Rifampin + TMP-SMX
6. TB endemic area: Consider DOX-STR or DOX-GENT to spare rifampin

Recent network meta-analyses suggest triple therapy (DOX + STR + hydroxychloroquine) may be superior, though this requires further validation 8, 9.